HC Wainwright & Co. Maintains Buy on Mind Medicine, Lowers Price Target to $35

Benzinga · 05/10 19:39
HC Wainwright & Co. analyst Patrick Trucchio maintains Mind Medicine (NASDAQ:MNMD) with a Buy and lowers the price target from $75 to $35.